Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
äŒæ¥ã³ãŒãXTNT
äŒç€ŸåXtant Medical Holdings Inc
äžå Žæ¥Jun 30, 2010
æé«çµå¶è²¬ä»»è
ãCEOãBrowne (Sean E)
åŸæ¥å¡æ°217
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jun 30
æ¬ç€Ÿæåšå°664 Cruiser Lane
éœåžBELGRADE
蚌åžååŒæNASDAQ OMX â NASDAQ Basic Amex
åœUnited States of America
éµäŸ¿çªå·59714
é»è©±çªå·14063880480
ãŠã§ããµã€ãhttps://xtantmedical.com/
äŒæ¥ã³ãŒãXTNT
äžå Žæ¥Jun 30, 2010
æé«çµå¶è²¬ä»»è
ãCEOãBrowne (Sean E)